Abstract:The phenotypic spectrum of genodermatoses is continuously expanding. Three siblings were referred because of a highly unusual phenotype comprising alopecia, dystrophic nails, palmoplantar keratoderma and trauma-induced skin blistering. Whole-exome sequencing analysis identified a heterozygous large genomic alteration of around 116 0000 bp resulting in the deletion of the KRT9, KRT14, KRT15, KRT16 and KRT19 genes, as well as part of KRT17. This genomic change leads to the generation of a truncated keratin 17 (KRT17) protein encoded by the first three exons of the gene and part of intron 3. The three patients were found to carry the heterozygous genomic deletion while their healthy parents did not, indicative of germline mosaicism. The genomic alteration was found to result in reduced KRT17 expression in patient skin. More importantly, the abnormal truncated KRT17 was found to exert a deleterious effect on keratinocyte cytoskeleton formation, leading to keratin aggregation. Coexpression of wildtype and truncated KRT17 proteins also caused keratin aggregation, demonstrating that the deletion exerts a dominant negative effect. In conclusion, we are reporting on a novel clinical phenotype that was found to result from germline mosaicism for a large genomic deletion spanning six keratin genes, thus expanding the spectrum of clinical manifestations associated with keratin disorders. What is already known about this topic? Various conditions known as keratinopathies have been shown over recent years to be associated with dominant or recessive variants in several individual keratin genes. What does this study add? We report three patients presenting with a unique clinical phenotype that was found to result from germline mosaicism for a large genomic deletion spanning six keratin genes. The genomic variant is predicted to result in a truncated form of keratin 17, which was found in an in vitro assay to disrupt keratinocyte cell cytoskeleton formation.

[Patterns on the skin. New aspects of their embryologic and genetic causes]

Four-dimensional, Dynamic Mosaicism is a Hallmark of Normal Human Skin That Permits Mapping of the Organization and Patterning of Human Epidermis During Terminal Differentiation.

Mosaic RASopathies concept: different skin lesions, same systemic manifestations?

Low-level germline mosaicism of a novel <i>SMARCA2</i> missense variant: Expanding the phenotypic spectrum and mode of genetic transmission

Body-wide chimerism and mosaicism are predominant causes of naturally occurring ABO discrepancies

[Diploid/triploid mosaicism: a variable but characteristic phenotype]

De novo mutations, genetic mosaicism and human disease

Mosaicism in Human Health and Disease.

A unique skin phenotype resulting from a large heterozygous deletion spanning six keratin genes

Somatic mosaicism detected by genome-wide sequencing in 500 parent-child trios with suspected genetic disease: clinical and genetic counseling implications

Mosaicism in health and disease — clones picking up speed

Human embryonic genetic mosaicism and its effects on development and disease

Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma

Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell

Facial Segmental Infantile Haemangioma: A Cutaneous Mosaicism Quandary

Phacomatosis spilosebacea: A new name for a distinctive binary genodermatosis

Epidermal nevi and epidermolytic hyperkeratosis: A review of cases, highlighting indications for biopsy and genetics referral

Identification of of a <i>PAX2</i> mutation from maternal mosaicism causes recurrent renal disorder in siblings

The Clinical Spectrum of Mosaic Genetic Disease

Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome

Recombination-induced revertant mosaicism in ichthyosis with confetti and loricrin keratoderma